Adverum Biotechnologies Inc (NASDAQ: ADVM) stock suffered a major decline of -11.1% on 3/31/20. The shares closed at $9.77. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -5.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, ADVM is expected to continue to be a major Value Eraser.
ADVM has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. ADVM has a very low Appreciation Score of 6 but a good Power Rating of 81, with the Negative Value Trend Rating the result.
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.